StonvexLoading…
StonvexStonvexStonvexCore line items from MCFT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-29 | Q4 2025 2025-12-28 | Q3 2025 2025-09-28 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $218.97M | $140.76M | $69.00M | $284.20M |
Operating Income | $5.20M | $6.50M | $3.78M | $11.23M |
Net Income | $5.42M | $2.53M | $3.64M | $7.04M |
EPS (Diluted) | $0.33 | $0.38 | $0.22 | $0.43 |
Total Assets | $277.85M | $259.68M | $259.31M | $259.95M |
Total Liabilities | $88.60M | $70.42M | $73.58M | $76.36M |
Cash & Equivalents | $75.40M | $56.23M | $31.76M | $28.93M |
Free Cash Flow OCF − CapEx | $7.79M | $4.04M | $-9.92M | $26.39M |
Shares Outstanding | 16.28M | 16.29M | 16.29M | 16.41M |